Page 101 - Demo

16. Choi H, Mook-Jung I. Functional effects of gut microbiotaderived metabolites in Alzheimer%u2019s disease. Curr OpNeurobiol. 2023;81:10273017. F%u00fclling C, Dinan TG, Cryan JF. Gut microbe to brainsignaling: what happens in vagus. Neuron.2019;101:998%u20131002.18. Morais LH, Schreiber HL Iv, Mazmanian SK. The gutmicrobiota%u2013brain axis in behaviour and brain disorders.Nat Rev Microbiol. 2021;19:241-55.19. Rothhammer v, Mascanfroni ID, bunse L, Takenaka MC,Kenison JE, Mayo L, et al. Type I interferons andmicrobial metabolites of tryptophan modulateastrocyte activity and central nervous systeminflammation via the aryl hydrocarbon receptor. NatMed. 2016;22:586%u201397.20. Toyofuku M, Nomura N, Eberl L. Types and origins ofbacterial membrane vesicles. Nat Rev Microbiol.2019;17:13-24.21. %u00d1ahui Palomino RA, vanpouille C, Costantini PE, MargolisL. Microbiota%u2013host communications: bacterialextracellular vesicles as a common language. PLoSPathog. 2021;17:e1009508.22. Xie J, Haesebrouck F, van Hoecke L, vandenbroucke RE.bacterial extracellular vesicles: An emerging avenueto tackle diseases. Trends Microbiol. 2023;31:1206-24.23. Sampson TR, Debelius Jw, Thron T, Janssen S, Shastri GG,Ilhan ZE, et al. Gut microbiota regulate motor deficitsand neuroinflammation in a model of Parkinson%u2019sdisease. Cell. 2016;167:1469%u201380.24. Rosario D, bidkhori G, Lee S, bedarf J, Hildebrand F, LeChatelier E. et al. Systematic analysis of gutmicrobiome reveals the role of bacterial folate andhomocysteine metabolism in Parkinson%u2019s disease. CellRep. 2021;34:108807.25. J. Soscia, J. E. Kirby, K. J. washicosky, S. M. Tucker, M.Ingelsson, b. Hyman, et al. The Alzheimer%u2019s diseaseassociated amyloid beta-protein is an antimicrobialpeptide. PLoS One. 2010;5:e9505.26. Spitzer P, Condic M, Herrmann M, Oberstein TJ, ScharinMehlmann M, Gilbert DF, et al. Amyloidogenicamyloid-beta-peptide variants induce microbialagglutination and exert antimicrobial activity. Sci Rep.2016;6:32228.27. Dominy SS, Lynch C, Ermini F, benedyk M, Marczyk A,Konradi A, et al. Porphyromonas gingivalis inAlzheimer%u2019s disease brains: Evidence for diseasecausation and treatment with small-moleculeinhibitors. Sci Adv. 2019;5:eaau3333.28. Liu S, butler CA, Ayton S, Reynolds EC, Dashper SG.Porphyromonas gingivalis and the pathogenesis ofAlzheimer%u2019s disease. Crit Rev Microbiol. 2023;doi:10.1080/1040841X.2022.2163613.29. Seo D, O%u2019Donnell D, Jain N, Ulrich JD, Herz J, Li y, et al.ApoE isoform%u2013 and microbiota-dependent progressionof neurodegeneration in a mouse model of tauopathy.Science. 2023;379:eadd1236.30. Minter MR, Zhang C, Leone v, Ringus DL, Zhang X, OylerCastrillo P, et al. Antibiotic-induced perturbations ingut microbial diversity influences neuro-inflammationand amyloidosis in a murine model of Alzheimer%u2019sdisease. Sci Rep. 2016;6:30028.AgradecimientosEl trabajo en el grupo del autor es parte del proyectode I+D+i con referencia PID2021-124866Ob-I00,financiado por MICIU/AEI/10.13039/501100011033,%u201cFEDER, una manera de hacer Europa%u201d. El autor est%u00e1 endeuda de gratitud con sus maestros cient%u00edficos, y consus compa%u00f1eros de laboratorio (estudiantes,doctorandos, posdoctorales, y t%u00e9cnicos) ycolaboradores, tanto en el CSIC como fuera del mismo,por la excepcional labor cient%u00edfica de %u00e9stos a lo largode casi cuatro d%u00e9cadas (1987-2024). Este art%u00edculo est%u00e1dedicado a la familia del autor por su afecto, est%u00edmulo,apoyo y comprensi%u00f3n.5. REFERENCIAS1. Proctor LM, Creasy HH, Fettweis JM, Lloyd-Price J,Mahurkar A, Zhou w, et al. The integrative humanmicrobiome project. Nature. 2019;569:641-8.2. Fung TC, Olson CA, Hsiao Ey. Interactions between themicrobiota, immune and nervous systems in health anddisease. Nat Neurosci. 2017;20:145%u201355.3. Sender R, Fuchs S, Milo R. Revised estimates for thenumber of human and bacteria cells in the body. PLoSbiol. 2016;14:e10002533.4. Lotz SK, blackhurst bM, Reagin KL, Funk KE. Microbialinfections are a risk factor for neurodegenerativediseases. Front Cell Neurosci. 2021;15:691136.5. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. Thecentral nervous system and the gut microbiome. Cell.2016;167:915%u201332.6. De la Fuente-Nuez C, Torres-Meneguetti b, Franco OL, LuTK. Neuromicrobiology: How microbes influence thebrain. ACS Chem Neurosci. 2018;9:141%u201350.7. Johnson ME, Stecher b, Labrie v, brundin L, brundin P.Triggers, facilitators, and aggravators: RedefiningParkinson%u2019s disease pathogenesis. Trends Neurosci.2019;42:4-13.8. bana b, Cabreiro F. The microbiome and aging. Annu RevGenet. 2019;53:239%u201361.9. Zhang H, Chen y, wang Z, Xie G, Liu M, yuan b, et al.Implications of gut microbiota in neurodegenerativediseases. Front Immunol. 2022;13:785644.10. wilson DM III, Cookson MR, van den bosch L, ZetterbergH, Holtzman DM, Dewachter I. Hallmarks ofneurodegenerative diseases. Cell. 2023;186:693%u201371411. Clerigu%u00e9-Louzado J, Mart%u00edn-C%u00e1mara O. La neurodegeneraci%u00f3n desde un punto de vista hol%u00edstico. An R Acad NacFarm. 2023;89:327-64.12. Schmidt TSb, Raes J, bork P. The human gut microbiome:From association to modulation. Cell. 2018;172:1198%u2013215.13. Cannon T, Gruenheld S. Microbes and Parkinson%u2019s disease:from associations to mechanisms. Trends Microbiol.2022;30:749-60.14. Friedland RP. Mechanisms of molecular mimicry involvingthe microbiota in neurodegeneration. J Alzheimers Dis.2015;45:349%u201362.15. Nicolas GR, Chang Pv. Deciphering the chemical lexiconof host%u2013gut microbiota interactions. Trends PharmacolSci. 2019;40:430%u20135.94ANALESRANFwww.analesranf.comMicrobiota as a %u2018black swan%u2019: The strange case of bacterialamyloids and neurodegenerationRafael Giraldo Su%u00e1rezAn. R. Acad. Farm.Vol. 90. n%u00ba 1 (2024) %u00b7 pp. 83-96